Table 1.
2001
|
2007
|
2001+2007
|
P* | P** | ||||
---|---|---|---|---|---|---|---|---|
Cons (n=706) | Inv (n=97) | Cons (n=463) | Inv (n=147) | Cons (n=1,169) | Inv (n=244) | |||
Age (mean ± SD; years) | 84±5 | 79±3 | 85±5 | 81±4 | 84±5 | 80±4 | <0.0001 | 0.33 |
Women | 53 | 40 | 57 | 46 | 55 | 43 | 0.053 | 0.83 |
Past medical history | ||||||||
Risk factors for AMI | ||||||||
Hypertension | 54 | 59 | 57a | 59a | 55a | 59a | 0.48 | 0.71 |
Diabetes | 21 | 20 | 28 | 24 | 24 | 22 | 0.18 | 0.69 |
Smoking at time of arrival | 10c | 14 | 7 | 11a | 9b | 12a | 0.64 | 0.89 |
Previous heart disease | ||||||||
Acute myocardial infarction | 44 | 31a | 44 | 36 | 44 | 34 | 0.03 | 0.59 |
Angina pectoris | 48 | 38 | 31a | 32a | 41a | 35a | 0.34 | 0.19 |
Cardiac arrest | 1a | 2 | 0 | 0a | <1 | < 1 | 1.00 | – |
CABG | 8 | 6 | 12 | 14a | 10 | 11 | 0.41 | 0.37 |
PCI | 3 | 8 | 7 | 19a | 4 | 14 | <0.0001 | 0.76 |
Congestive heart failure | 44 | 16 | 36 | 11 | 41 | 13 | <0.0001 | 0.69 |
Atrial fibrillation | 29 | 8 | 27 | 20a | 28 | 15a | 0.001 | 0.003 |
Other vascular disease | ||||||||
Peripheral vascular disease | 14a | 20 | 13 | 9 | 14 | 13 | 0.44 | 0.04 |
Cerebrovascular disease | 25 | 12 | 24 | 13 | 24 | 13 | 0.0002 | 0.77 |
Other disease | ||||||||
COPD | 12 | 10 | 13 | 10 | 12 | 10 | 0.03 | 0.67 |
Connective tissue disease | 3 | 0 | 0 | 0 | 2 | 0 | 0.03 | – |
Non-metastatic tumor | 11a | 7 | 6 | 4 | 9 | 5 | 0.09 | 0.82 |
Metastatic tumor | 6a | 3 | 12 | 6 | 9 | 5 | 0.08 | 0.97 |
Renal disease | 9a | 8 | 13 | 7 | 9 | 7 | 0.08 | 0.27 |
Treated at hospital with PCI facilities | 48 | 75 | 55 | 56 | 51 | 64 | 0.003 | 0.0001 |
Notes:
For difference between conservative and invasive treated groups (age adjusted);
for time period by treatment interaction;
1%–5% missing;
5%–10% missing;
10%–25% missing.
Abbreviations: Cons, conservative; Inv, invasive; SD, standard deviation; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; COPD, chronic obstructive pulmonary disease; AMI, acute myocardial infarction.